AMRUTANJAN.NS

Amrutanjan Health Care Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$545.45

-0.08%Jun 19, 2026

AI Brief

Market cap

$15.76B

52w range

—

P / E

—

EPS · FY 2026

$20.03

Volume

—

Revenue · FY 2026

$5.03B

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Amrutanjan Health Care Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$545.45

Change

-25.30%

Period high

$768.35

Period low

$493.65

Period start

$730.152025-06-23

Through 2026-06-19

Fair value

Football field →

Weighted blend

$440.89

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

AMRUTANJAN.NS

545.45-25.30%

H 790.95L 486.00MA50 555.50MA200 631.85Avg vol 22K

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Communication Services
+1.85%
Utilities
+1.35%
Consumer Cyclical
+0.30%
Energy
-0.45%
Industrials
-0.48%
Basic Materials
-0.66%
Financial Services
-0.67%
Technology
-0.95%
Healthcare
-1.51%
Consumer Defensive
-1.52%
Real Estate
-2.19%

Top industries (issuer's industry highlighted)

Drug Manufacturers - Specialty & Generic
-1.01%
Oil & Gas Energy
+8.53%
Auto - Dealerships
-6.22%
Business Equipment & Supplies
+5.82%
Advertising Agencies
-5.20%
Grocery Stores
-4.35%
Financial - Mortgages
+4.08%
Broadcasting
+4.00%
REIT - Office
-3.71%
Computer Hardware
-3.67%
Other Precious Metals
-3.55%
REIT - Diversified
-3.43%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for AMRUTANJAN.NS.

Peers

No peer list available for AMRUTANJAN.NS.

Total assets

$5.09B

Total debt

$17.77M

Cash & equiv

$333.25M

Operating CF

$518.88M

Free cash flow

-$31.16M

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$5.03B	$693.66M	$579.18M	$20.03	+11.52%